A randomised controlled study of N-Acetylcysteine in liver transplantation

INTERVENTION: Patients undergoing liver transplantation will be randomly allocated to the N‐Acetylcysteine group or a control group (no treatment). Treatment will commence during the liver transplant and continue for 5 days post‐operatively. Blood tests and liver biopsies will be taken during the study for analysis. CONDITION: Surgery: Liver transplant ; Surgery ; Liver transplant PRIMARY OUTCOME: Not provided at time of registration ; SECONDARY OUTCOME: Not provided at time of registration ; INCLUSION CRITERIA: Added May 2008: Adult patients (=18years) undergoing liver transplant